Assessing the Potential Adoption of Psychedelic Medicine in Health Care Systems
December 28th 2021Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses whether the adoption and acknowledgement of psychedelic medicine in health care systems looks likely for the future.
Watch
Assessing the Ideal Environments in Which Psychedelic Medicines Should Be Administered
December 27th 2021Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses which environments each psychedelic medicine is likely to be administered.
Watch
Expert: NIH Encourages Data from Clinical Trials be Disaggregated by Sex in Reporting
December 24th 2021Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health at the National Institutes of Health, discusses how clinical trials have evolved to address biological and sociological variables in patient health.
Watch
How Trial Results Assessing Dara-KRd in Multiple Myeloma May Impact the Treatment Landscape
December 24th 2021Luciano Costa, MD, PhD, of the University of Alabama at Birmingham, discusses how the results of the trial assessing daratumumab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma may impact the treatment landscape.
Watch
The Psychedelic Drugs Currently Under Investigation for Potential FDA Approval
December 24th 2021Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses which psychedelic drugs are currently under investigation for potential FDA approval.
Watch
Expert: US Drug Shortages May Not Be Associated With Problems in the Global Supply Chain
December 24th 2021Andrew Mulcahy, PhD, a senior policy researcher at RAND Corporation, discusses a recent report that showed the drug shortages in the United States may not be associated with problems in the global supply chain.
Watch
Expert: 'We Cannot Overstate or Ignore' Relationship Between Diabetes, COVID-19 Infection Risk
December 24th 2021Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses how the diabetes DRIVE program compares with the SHC DRIVE models for flu and COVID-19 vaccinations.
Watch